Mass Inoculation Against Covid-19 in Brazil “Only Possible” in March with the AstraZeneca Vaccine

The AstraZeneca vaccine was Brazil’s main bet, with a R$1.9 billion (US$371.6 million) deal in June securing raw materials and the transfer of production technology to Fiocruz. Despite long being the world frontrunner, AstraZeneca’s shot has been overtaken by Pfizer’s.

RIO DE JANEIRO, BRAZIL - In Brazil, a mass inoculation campaign against Covid 19 will only be possible from March and will rely on the Astra Zeneca vaccine, a senior health official at the country’s leading public biomedical institute told Reuters.

The comments come as a fresh wave of coronavirus infections devastates Brazil, which has the world’s second-highest death toll from the pandemic with over 180,000 dead, behind only the United States.

As Britain and the United States begin immunizations using the shot developed by Pfizer, pressure is mounting on Brazil’s Health Ministry to quickly make . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?